ArticleBlood cancer journal2021

XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis.

Eline Boons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.